Skip to main content
Erschienen in: Infection 4/2017

01.03.2017 | Review

Pyogenic arthritis, pyoderma gangrenosum, and acne (PAPA) syndrome: differential diagnosis of septic arthritis by regular detection of exceedingly high synovial cell counts

verfasst von: W. Löffler, P. Lohse, T. Weihmayr, W. Widenmayer

Erschienen in: Infection | Ausgabe 4/2017

Einloggen, um Zugang zu erhalten

Abstract

Pyogenic arthritis, pyoderma gangrenosum and acne syndrome was diagnosed in a 42-year-old patient, after an unusual persistency of high synovial cell counts had been noticed. Clinical peculiarities and problems with diagnosing septic versus non-septic arthritis are discussed.
Literatur
1.
Zurück zum Zitat Schulz BM, Watling JP, Vosseller T, Strauch RJ. Markedly elevated intra-articular white cell count caused by gout alone. Orthopedics. 2014;37:e739–42.CrossRefPubMed Schulz BM, Watling JP, Vosseller T, Strauch RJ. Markedly elevated intra-articular white cell count caused by gout alone. Orthopedics. 2014;37:e739–42.CrossRefPubMed
2.
Zurück zum Zitat Lindor NM, Arsenault TM, Solomon H, Seidman CE, McEvoy MT. A new autosomal dominant disorder of pyogenic sterile arthritis, pyoderma gangrenosum, and acne: PAPA syndrome. Mayo Clin Proc. 1997;72:611–5.CrossRefPubMed Lindor NM, Arsenault TM, Solomon H, Seidman CE, McEvoy MT. A new autosomal dominant disorder of pyogenic sterile arthritis, pyoderma gangrenosum, and acne: PAPA syndrome. Mayo Clin Proc. 1997;72:611–5.CrossRefPubMed
3.
Zurück zum Zitat Holzinger D, Roth J. Alarming consequences—autoinflammatory disease spectrum due to mutations in proline-serine-threonine phosphatase-interacting protein 1. Curr Opin Rheumatol. 2016;28:550–9.CrossRefPubMed Holzinger D, Roth J. Alarming consequences—autoinflammatory disease spectrum due to mutations in proline-serine-threonine phosphatase-interacting protein 1. Curr Opin Rheumatol. 2016;28:550–9.CrossRefPubMed
4.
Zurück zum Zitat Wise CA, Bennett LB, Pascual V, Gillum JD, Bowcock AM. Localization of a gene for familial recurrent arthritis. Arthritis Rheum. 2000;43:2041–5.CrossRefPubMed Wise CA, Bennett LB, Pascual V, Gillum JD, Bowcock AM. Localization of a gene for familial recurrent arthritis. Arthritis Rheum. 2000;43:2041–5.CrossRefPubMed
5.
Zurück zum Zitat Shoham NG, Centola M, Mansfield E, Hull KM, Wood G, Wise CA, Kastner DL. Pyrin binds the PSTPIP1/CD2BP1 protein, defining familial Mediterranean fever and PAPA syndrome as disorders in the same pathway. Proc Natl Acad Sci USA. 2003;100:13501–6.CrossRefPubMedPubMedCentral Shoham NG, Centola M, Mansfield E, Hull KM, Wood G, Wise CA, Kastner DL. Pyrin binds the PSTPIP1/CD2BP1 protein, defining familial Mediterranean fever and PAPA syndrome as disorders in the same pathway. Proc Natl Acad Sci USA. 2003;100:13501–6.CrossRefPubMedPubMedCentral
7.
Zurück zum Zitat Schellevis MA, Stoffels M, Hoppenreijs EPAH, Bodar E, Simon A, van der Meer JWM. Variable expression and treatment of PAPA syndrome. Ann Rheum Dis. 2011;70:1168–70.CrossRefPubMed Schellevis MA, Stoffels M, Hoppenreijs EPAH, Bodar E, Simon A, van der Meer JWM. Variable expression and treatment of PAPA syndrome. Ann Rheum Dis. 2011;70:1168–70.CrossRefPubMed
8.
Zurück zum Zitat Demidowich AP, Freeman AF, Kuhns DB, Aksentijevich I, Gallin JI, Turner ML, et al. Genotype, phenotype, and Clinical Course in five patients with PAPA syndrome (pyogenic arthritis, pyoderma gangrenosum, and acne). Arthritis Rheum. 2012;64:2022–7.CrossRefPubMed Demidowich AP, Freeman AF, Kuhns DB, Aksentijevich I, Gallin JI, Turner ML, et al. Genotype, phenotype, and Clinical Course in five patients with PAPA syndrome (pyogenic arthritis, pyoderma gangrenosum, and acne). Arthritis Rheum. 2012;64:2022–7.CrossRefPubMed
9.
Zurück zum Zitat Holzinger D, Fassl SK, de Jager W, Lohse P, Röhrig UF, Gattorno M, et al. Single amino acid charge switch defines clinically distinct proline-serine-threonine phosphatase-interacting protein 1 (PSTPIP1)-associated inflammatory diseases. J Allergy Clin Immunol. 2015;136:1337–45.CrossRefPubMed Holzinger D, Fassl SK, de Jager W, Lohse P, Röhrig UF, Gattorno M, et al. Single amino acid charge switch defines clinically distinct proline-serine-threonine phosphatase-interacting protein 1 (PSTPIP1)-associated inflammatory diseases. J Allergy Clin Immunol. 2015;136:1337–45.CrossRefPubMed
10.
Zurück zum Zitat Caorsi R, Picco P, Buoncompagni A, Martini A, Gattorno M. Osteolytic lesion in PAPA syndrome responding to anti-interleukin 1 treatment. J Rheumatol. 2014;41:2333–4.CrossRefPubMed Caorsi R, Picco P, Buoncompagni A, Martini A, Gattorno M. Osteolytic lesion in PAPA syndrome responding to anti-interleukin 1 treatment. J Rheumatol. 2014;41:2333–4.CrossRefPubMed
11.
Zurück zum Zitat Marzano AV, Trevisan V, Gattorno M, Ceccherini I, De Simone C, Crosti C. Pyogenic arthritis, pyoderma gangrenosum, acne, and hidradenitis suppurativa (PAPASH): a new autoinflammatory syndrome associated with a novel mutation of the PSTPIP1 gene. JAMA Dermatol. 2013;149:762–4.CrossRefPubMed Marzano AV, Trevisan V, Gattorno M, Ceccherini I, De Simone C, Crosti C. Pyogenic arthritis, pyoderma gangrenosum, acne, and hidradenitis suppurativa (PAPASH): a new autoinflammatory syndrome associated with a novel mutation of the PSTPIP1 gene. JAMA Dermatol. 2013;149:762–4.CrossRefPubMed
12.
Zurück zum Zitat Calderon-Castrat X, Bancalari-Diaz D, Roman-Curto C, Romo-Melgar A, Amoros-Cerdan D, Alcaraz-Mas LA, et al. PSTPIP1 gene mutation in a pyoderma gangrenosum, acne and suppurative hidradenitis (PASH) syndrome. Br J Dermatol. 2016;175:194–8.CrossRefPubMed Calderon-Castrat X, Bancalari-Diaz D, Roman-Curto C, Romo-Melgar A, Amoros-Cerdan D, Alcaraz-Mas LA, et al. PSTPIP1 gene mutation in a pyoderma gangrenosum, acne and suppurative hidradenitis (PASH) syndrome. Br J Dermatol. 2016;175:194–8.CrossRefPubMed
13.
Zurück zum Zitat Zeeli T, Padalon-Brauch G, Ellenbogen E, Gat A, Sarig O, Sprecher E. Pyoderma gangrenosum, acne and ulcerative colitis in a patient with a novel mutation in the PSTPIP1 gene. Clin Exp Dermatol. 2015;40:367–72.CrossRefPubMed Zeeli T, Padalon-Brauch G, Ellenbogen E, Gat A, Sarig O, Sprecher E. Pyoderma gangrenosum, acne and ulcerative colitis in a patient with a novel mutation in the PSTPIP1 gene. Clin Exp Dermatol. 2015;40:367–72.CrossRefPubMed
14.
Zurück zum Zitat Khatibi K, Heit JJ, Telischak NA, Elbers JM, Do HM. Cerebral vascular findings in PAPA syndrome: cerebral arterial vasculopathy or vasculitis and a posterior cerebral artery dissecting aneurysm. BMJ Case Rep. 2015. doi:10.1136/bcr-2015-011753.PubMedPubMedCentral Khatibi K, Heit JJ, Telischak NA, Elbers JM, Do HM. Cerebral vascular findings in PAPA syndrome: cerebral arterial vasculopathy or vasculitis and a posterior cerebral artery dissecting aneurysm. BMJ Case Rep. 2015. doi:10.​1136/​bcr-2015-011753.PubMedPubMedCentral
15.
Zurück zum Zitat Jacobs JC, Goetzl EJ. “Streaking leucocyte factor”, arthritis, and pyoderma gangrenosum. Pediatrics. 1975;56:570–8.PubMed Jacobs JC, Goetzl EJ. “Streaking leucocyte factor”, arthritis, and pyoderma gangrenosum. Pediatrics. 1975;56:570–8.PubMed
16.
Zurück zum Zitat Wise CA, Gillum JD, Seidman CE, Lindor NM, Veile R, Bashiardes S, Lovett M. Mutations in CD2BP1 disrupt binding to PTP PEST and are responsible for PAPA syndrome, an autoinflammatory disorder. Human Molec Genet. 2002;11:961–9.CrossRef Wise CA, Gillum JD, Seidman CE, Lindor NM, Veile R, Bashiardes S, Lovett M. Mutations in CD2BP1 disrupt binding to PTP PEST and are responsible for PAPA syndrome, an autoinflammatory disorder. Human Molec Genet. 2002;11:961–9.CrossRef
17.
Zurück zum Zitat Masters SL, Simon A, Aksentijevich I, Kastner DL. Horror autoinflammaticus: the molecular pathphysiology of autoinflammatory disease. Ann Rev Immunol. 2009;27:621–68.CrossRef Masters SL, Simon A, Aksentijevich I, Kastner DL. Horror autoinflammaticus: the molecular pathphysiology of autoinflammatory disease. Ann Rev Immunol. 2009;27:621–68.CrossRef
18.
Zurück zum Zitat Smith EJ, Allantaz F, Bennett L, Zhang D, Gao X, Wood G, et al. Clinical, molecular, and genetic characteristics of PAPA syndrome: a review. Curr Genomics. 2010;11:519–27.CrossRefPubMedPubMedCentral Smith EJ, Allantaz F, Bennett L, Zhang D, Gao X, Wood G, et al. Clinical, molecular, and genetic characteristics of PAPA syndrome: a review. Curr Genomics. 2010;11:519–27.CrossRefPubMedPubMedCentral
19.
Zurück zum Zitat Hedrich CM, Hofmann SR, Pablik J, Morbach H, Girschick HJ. Autoinflammatory bone disorders with special focus on chronic recurrent multifocal osteomyelitis (CRMO). Pediatr Rheum. 2013;11:47–55.CrossRef Hedrich CM, Hofmann SR, Pablik J, Morbach H, Girschick HJ. Autoinflammatory bone disorders with special focus on chronic recurrent multifocal osteomyelitis (CRMO). Pediatr Rheum. 2013;11:47–55.CrossRef
20.
Zurück zum Zitat Stichweh DS, Punaro M, Pascual V. Dramatic improvement of pyoderma gangrenosum with infliximab in a patient with PAPA syndrome. Pediatr Dermatol. 2005;22:262–5.CrossRefPubMed Stichweh DS, Punaro M, Pascual V. Dramatic improvement of pyoderma gangrenosum with infliximab in a patient with PAPA syndrome. Pediatr Dermatol. 2005;22:262–5.CrossRefPubMed
21.
Zurück zum Zitat Yeon HB, Lindor NM, Seidman JG, Seidman CE. Pyogenic arthritis, pyoderma gengrenosum, and acne syndrome maps to chromosome 15q. Am J Hum Genet. 2000;66:1443–8.CrossRefPubMedPubMedCentral Yeon HB, Lindor NM, Seidman JG, Seidman CE. Pyogenic arthritis, pyoderma gengrenosum, and acne syndrome maps to chromosome 15q. Am J Hum Genet. 2000;66:1443–8.CrossRefPubMedPubMedCentral
22.
Zurück zum Zitat Chen W, Obermayer-Pietsch B, Hong J-B, Melnik BC, Yamasaki O, Dessinioti C, et al. Acne-associated syndromes: models for better understanding of acne pathogenesis. J Eur Acad Dermato Venerol. 2011;25:637–46.CrossRef Chen W, Obermayer-Pietsch B, Hong J-B, Melnik BC, Yamasaki O, Dessinioti C, et al. Acne-associated syndromes: models for better understanding of acne pathogenesis. J Eur Acad Dermato Venerol. 2011;25:637–46.CrossRef
23.
Zurück zum Zitat Hong JB, Prucha H, Melnik B, Ziai M, Ring J, Chen W. Seltene Akne-assoziierte Syndrome und deren Bedeutung für das Verständnis der Pathogenese der Akne. Hautarzt. 2013;64:274–9.CrossRefPubMed Hong JB, Prucha H, Melnik B, Ziai M, Ring J, Chen W. Seltene Akne-assoziierte Syndrome und deren Bedeutung für das Verständnis der Pathogenese der Akne. Hautarzt. 2013;64:274–9.CrossRefPubMed
24.
Zurück zum Zitat Renn CN, Helmer A, Megahed M. Pyogene Arthritis, Pyoderma gangrenosum und Akne-Syndrom (PAPA-Syndrom). Hautarzt. 2007;58:383–4.CrossRefPubMed Renn CN, Helmer A, Megahed M. Pyogene Arthritis, Pyoderma gangrenosum und Akne-Syndrom (PAPA-Syndrom). Hautarzt. 2007;58:383–4.CrossRefPubMed
25.
Zurück zum Zitat Hong JB, Su YN, Chiu HC. Pyogenic arthritis, pyoderma gangrenosum, and acne syndrome (PAPA syndrome): report of a sporadic case without an identifiable mutation in the CD2BP1 gene. J Am Acad Dermatol. 2009;61:533–5.CrossRefPubMed Hong JB, Su YN, Chiu HC. Pyogenic arthritis, pyoderma gangrenosum, and acne syndrome (PAPA syndrome): report of a sporadic case without an identifiable mutation in the CD2BP1 gene. J Am Acad Dermatol. 2009;61:533–5.CrossRefPubMed
26.
Zurück zum Zitat Dierselhuis MP, Frenkel J, Wulffraat NM, Boelens JJ. Anakinra for flares of pyogenic arthritis in PAPA syndrome. Rheumatology. 2005;44:406–8.CrossRefPubMed Dierselhuis MP, Frenkel J, Wulffraat NM, Boelens JJ. Anakinra for flares of pyogenic arthritis in PAPA syndrome. Rheumatology. 2005;44:406–8.CrossRefPubMed
27.
Zurück zum Zitat Glaser RL, Goldbach-Mansky R. The spectrum of monogenic autoinflammatory syndromes: understanding disease mechanisms and use of targeted therapies. Curr Allergy Asthma Rep. 2008;8:288–98.CrossRefPubMedPubMedCentral Glaser RL, Goldbach-Mansky R. The spectrum of monogenic autoinflammatory syndromes: understanding disease mechanisms and use of targeted therapies. Curr Allergy Asthma Rep. 2008;8:288–98.CrossRefPubMedPubMedCentral
29.
Zurück zum Zitat Ahmadinejad Z, Mansouri S, Ziaee V, Aghighi Y, Moradinejad H, Fereshteh-Mehregan F. Periodic fever: a review on clinical, management and guideline for Iranian patients—part II. Iran J Pediatr. 2014;24:229–40.PubMedPubMedCentral Ahmadinejad Z, Mansouri S, Ziaee V, Aghighi Y, Moradinejad H, Fereshteh-Mehregan F. Periodic fever: a review on clinical, management and guideline for Iranian patients—part II. Iran J Pediatr. 2014;24:229–40.PubMedPubMedCentral
30.
Zurück zum Zitat Geusau A, Mothes-Luksch N, Nahavandi H, Pickl W, Wise CA, Pourpak Z, et al. Identification of a homozygous PSTPIP1 mutation in a patient with a PAPA-like syndrome responding to canakinumab treatment. JAMA Dermatol. 2013;149:209–15.CrossRefPubMed Geusau A, Mothes-Luksch N, Nahavandi H, Pickl W, Wise CA, Pourpak Z, et al. Identification of a homozygous PSTPIP1 mutation in a patient with a PAPA-like syndrome responding to canakinumab treatment. JAMA Dermatol. 2013;149:209–15.CrossRefPubMed
31.
Zurück zum Zitat Nesterovitch AB, Hoffman MD, Simon M, Petukhov PA, Tharp MD, Glantt TT. Mutations in the PSTPIP1 geme and aberrant splicing variants in patients with pyoderma gangrenosum. Clin Exp Dermatol. 2011;36:889–95.CrossRefPubMed Nesterovitch AB, Hoffman MD, Simon M, Petukhov PA, Tharp MD, Glantt TT. Mutations in the PSTPIP1 geme and aberrant splicing variants in patients with pyoderma gangrenosum. Clin Exp Dermatol. 2011;36:889–95.CrossRefPubMed
32.
Zurück zum Zitat Cortis E, De Benedetti F, Insalaco A, Cioshi S, Muratori F, D´Urbano LE, Ugazio AG. Abnormal production of the tumor necrosis factor inhibitor etanercept and clinical efficacy of tumor in a patient with PAPA syndrome. J Pediatrics. 2004;145:851–5.CrossRef Cortis E, De Benedetti F, Insalaco A, Cioshi S, Muratori F, D´Urbano LE, Ugazio AG. Abnormal production of the tumor necrosis factor inhibitor etanercept and clinical efficacy of tumor in a patient with PAPA syndrome. J Pediatrics. 2004;145:851–5.CrossRef
34.
Zurück zum Zitat Edrees AF, Kaplan DL, Abdou NI. Pyogenic arthritis, pyoderma gangrenosum, and acne syndrome (PAPA syndrome) associated with hypogammaglobulinemia and elevated tumor necrosis factor-alpha levels. J Clin Rheumatol. 2002;8:273–5.CrossRefPubMed Edrees AF, Kaplan DL, Abdou NI. Pyogenic arthritis, pyoderma gangrenosum, and acne syndrome (PAPA syndrome) associated with hypogammaglobulinemia and elevated tumor necrosis factor-alpha levels. J Clin Rheumatol. 2002;8:273–5.CrossRefPubMed
35.
Zurück zum Zitat Tofteland ND, Shaver TS. Clinical efficacy of etanercept for treatment of PAPA syndrome. J Clin Rheumatol. 2010;16:244–5.CrossRefPubMed Tofteland ND, Shaver TS. Clinical efficacy of etanercept for treatment of PAPA syndrome. J Clin Rheumatol. 2010;16:244–5.CrossRefPubMed
36.
Zurück zum Zitat Furst DE, Gaylis N, Bray V, Olech E, Yocum D, Ritter J, et al. Open-label, pilot protocol of patients with rheumatoid arthritis who switch to infliximab after an incomplete response to etanercept: the opposite study. Ann Rheum Dis. 2007;66:893–9.CrossRefPubMedPubMedCentral Furst DE, Gaylis N, Bray V, Olech E, Yocum D, Ritter J, et al. Open-label, pilot protocol of patients with rheumatoid arthritis who switch to infliximab after an incomplete response to etanercept: the opposite study. Ann Rheum Dis. 2007;66:893–9.CrossRefPubMedPubMedCentral
37.
Zurück zum Zitat de Almeida Jesus A, Goldbach-Mansky R. Monogenic autoinflammatory diseases: concept and clinical manifestations. Clin Immunol. 2013;147:155–217.CrossRef de Almeida Jesus A, Goldbach-Mansky R. Monogenic autoinflammatory diseases: concept and clinical manifestations. Clin Immunol. 2013;147:155–217.CrossRef
39.
Zurück zum Zitat Ter Haar N, Lachmann H, Özen S, Woo P, Uziel Y, Modesto C, et al. Treatment of autoinflammatory diseases: results from the eurofever registry and a literature review. Ann Rheum Dis. 2013;72:678–85.CrossRefPubMed Ter Haar N, Lachmann H, Özen S, Woo P, Uziel Y, Modesto C, et al. Treatment of autoinflammatory diseases: results from the eurofever registry and a literature review. Ann Rheum Dis. 2013;72:678–85.CrossRefPubMed
40.
Zurück zum Zitat Brenner M, Ruzicka T, Plewig G, Thomas P, Herzer P. Targeted treatment of pyoderma gangrenosum in PAPA (pyogenic arthritis, pyoderma gangrenosum and acne) syndrome with the recombinant human interleukin-1 receptor antagonist anakinra. Br J Dermatol. 2009;161:1199–201.CrossRefPubMed Brenner M, Ruzicka T, Plewig G, Thomas P, Herzer P. Targeted treatment of pyoderma gangrenosum in PAPA (pyogenic arthritis, pyoderma gangrenosum and acne) syndrome with the recombinant human interleukin-1 receptor antagonist anakinra. Br J Dermatol. 2009;161:1199–201.CrossRefPubMed
41.
Zurück zum Zitat Finetti M, Caorsi R, Marotto D, Buoncompagni A, Omenetti A, Lattanzi B, et al. Long-term efficacy of IL-1 blockers in PAPA patients. Pediatr Rheumatol. 2015;13(Suppl 1):P-207. Finetti M, Caorsi R, Marotto D, Buoncompagni A, Omenetti A, Lattanzi B, et al. Long-term efficacy of IL-1 blockers in PAPA patients. Pediatr Rheumatol. 2015;13(Suppl 1):P-207.
42.
Zurück zum Zitat Krey PR, Bailen DA. Synovial fluid leukocytosis—a study of extremes. Am J Med. 1979;67:436–42.CrossRefPubMed Krey PR, Bailen DA. Synovial fluid leukocytosis—a study of extremes. Am J Med. 1979;67:436–42.CrossRefPubMed
43.
Zurück zum Zitat Kowalski TJ, Thompson LA, Gundrum JD. Antimicrobial management of septic arthritis of the hand and wrist. Infection. 2014;42:379–84.CrossRefPubMed Kowalski TJ, Thompson LA, Gundrum JD. Antimicrobial management of septic arthritis of the hand and wrist. Infection. 2014;42:379–84.CrossRefPubMed
44.
Zurück zum Zitat Gupta MN, Sturrock RD, Field M. Prospective comparative study of patients with culture proven and high suspicion of adult onset septic arthritis. Ann Rheum Dis. 2003;62:327–31.CrossRefPubMedPubMedCentral Gupta MN, Sturrock RD, Field M. Prospective comparative study of patients with culture proven and high suspicion of adult onset septic arthritis. Ann Rheum Dis. 2003;62:327–31.CrossRefPubMedPubMedCentral
45.
Zurück zum Zitat Eberst-Ledoux J, Tournadre A, Mathieu S, Mrozek N, Soubrier M. Dubost. Septic arthritis with negative bacteriological findings in adult native joints: a retrospective study of 74 cases. Joint Bone Spine. 2012;79:156–9.CrossRefPubMed Eberst-Ledoux J, Tournadre A, Mathieu S, Mrozek N, Soubrier M. Dubost. Septic arthritis with negative bacteriological findings in adult native joints: a retrospective study of 74 cases. Joint Bone Spine. 2012;79:156–9.CrossRefPubMed
46.
Zurück zum Zitat Alijanipour P, Adeli B, Hansen EN, Chen AF, Parvizi J. Intraoperative purulence is not reliable for diagnosing periprosthetic joint infection. J Arthroplasty. 2015;30:1403–6.CrossRefPubMed Alijanipour P, Adeli B, Hansen EN, Chen AF, Parvizi J. Intraoperative purulence is not reliable for diagnosing periprosthetic joint infection. J Arthroplasty. 2015;30:1403–6.CrossRefPubMed
47.
Zurück zum Zitat Lenski M, Scherer MA. Diagnostic potential of inflammatory markers in septic arthritis and periprosthetic joint infections: a clinical study with 719 patients. Infect Dis. 2015;47:399–409.CrossRef Lenski M, Scherer MA. Diagnostic potential of inflammatory markers in septic arthritis and periprosthetic joint infections: a clinical study with 719 patients. Infect Dis. 2015;47:399–409.CrossRef
48.
Zurück zum Zitat De Angelis G, Mutters NT, Minkley L, Holderried F, Tacconelli E. Prosthetic joint infections in the elderly. Infection. 2015;43:629–37.CrossRefPubMed De Angelis G, Mutters NT, Minkley L, Holderried F, Tacconelli E. Prosthetic joint infections in the elderly. Infection. 2015;43:629–37.CrossRefPubMed
49.
50.
Zurück zum Zitat Borde JP, Häcker GA, Guschl S, Serr A, Danner T, Hübner J, Burrack-Lange S, Lüdke G, Helwig P, Hauschild O, Kern WV. Diagnosis of prosthetic joint infections using UMD-Universal Kit and the automated multiplex-PCR Unyvero i60 ITI(®) cartridge system: a pilot study. Infection. 2015;43:551–60.CrossRefPubMed Borde JP, Häcker GA, Guschl S, Serr A, Danner T, Hübner J, Burrack-Lange S, Lüdke G, Helwig P, Hauschild O, Kern WV. Diagnosis of prosthetic joint infections using UMD-Universal Kit and the automated multiplex-PCR Unyvero i60 ITI(®) cartridge system: a pilot study. Infection. 2015;43:551–60.CrossRefPubMed
51.
Zurück zum Zitat Lepetit C, Le Gal S, Michon J, Collon S, Tillou X. Pseudomonas aeruginosa septic trapezo-metacarpal arthritis after prostate laser vaporization. Infection. 2015;43:503–5.CrossRefPubMed Lepetit C, Le Gal S, Michon J, Collon S, Tillou X. Pseudomonas aeruginosa septic trapezo-metacarpal arthritis after prostate laser vaporization. Infection. 2015;43:503–5.CrossRefPubMed
52.
Zurück zum Zitat Madruga Dias J, Costa MM, da Pereira JA, de Viana Queiroz M. Septic arthritis: patients with or without isolated infectious agents have similar characteristics. Infection. 2014;42:385–91.CrossRefPubMed Madruga Dias J, Costa MM, da Pereira JA, de Viana Queiroz M. Septic arthritis: patients with or without isolated infectious agents have similar characteristics. Infection. 2014;42:385–91.CrossRefPubMed
53.
Zurück zum Zitat Wang C, Zhong D, Liao Q, Kong L, Liu A, Xiao H. Procalcitonin levels in fresh serum and fresh synovial fluid for the differential diagnosis of knee septic arthritis from rheumatoid arthritis, osteoarthritis and gouty arthritis. Exp Ther Med. 2014;8:1075–80.PubMedPubMedCentral Wang C, Zhong D, Liao Q, Kong L, Liu A, Xiao H. Procalcitonin levels in fresh serum and fresh synovial fluid for the differential diagnosis of knee septic arthritis from rheumatoid arthritis, osteoarthritis and gouty arthritis. Exp Ther Med. 2014;8:1075–80.PubMedPubMedCentral
54.
Zurück zum Zitat Saeed K, Dryden M, Sitjar A, White G. Measuring synovial fluid procalcitonin levels in distinguishing cases of septic arthritis, including prosthetic joints, from other causes of arthritis and septic loosening. Infection. 2013;41:845–9.CrossRefPubMed Saeed K, Dryden M, Sitjar A, White G. Measuring synovial fluid procalcitonin levels in distinguishing cases of septic arthritis, including prosthetic joints, from other causes of arthritis and septic loosening. Infection. 2013;41:845–9.CrossRefPubMed
55.
Zurück zum Zitat Lindwall E, Singla S, Davis WE, Quinet RJ. Novel PSTPIP1 gene mutation in a patient with pyogenic arthritis, pyoderma gangrenosum and acne (PAPA) syndrome. Sem Arthritis Rheum. 2015;45:91–3.CrossRef Lindwall E, Singla S, Davis WE, Quinet RJ. Novel PSTPIP1 gene mutation in a patient with pyogenic arthritis, pyoderma gangrenosum and acne (PAPA) syndrome. Sem Arthritis Rheum. 2015;45:91–3.CrossRef
56.
Zurück zum Zitat Heller H, Gafni J, Michaeli D, Shahin N, Sohar E, Ehrlich G, et al. The arthritis of familial mediterranean fever (FMF). Arthritis Rheum. 1966;9:1–17.CrossRefPubMed Heller H, Gafni J, Michaeli D, Shahin N, Sohar E, Ehrlich G, et al. The arthritis of familial mediterranean fever (FMF). Arthritis Rheum. 1966;9:1–17.CrossRefPubMed
57.
Zurück zum Zitat Taarit CB, Turki S, Maiz HB. Les manifestations rhumatologiques de la maladie de Behcet: à propos de 309 cas. Rev Med Interne. 2001;22:1049–55.CrossRefPubMed Taarit CB, Turki S, Maiz HB. Les manifestations rhumatologiques de la maladie de Behcet: à propos de 309 cas. Rev Med Interne. 2001;22:1049–55.CrossRefPubMed
58.
Zurück zum Zitat Daikh BE, Emerson FE, Smith RP, Lucas FL, McCarthy CA. Lyme arthritis: a comparison of presentation, synovial fluid analysis, and treatment course in children and adults. Arthritis Care Research. 2013;65:1986–90.CrossRefPubMed Daikh BE, Emerson FE, Smith RP, Lucas FL, McCarthy CA. Lyme arthritis: a comparison of presentation, synovial fluid analysis, and treatment course in children and adults. Arthritis Care Research. 2013;65:1986–90.CrossRefPubMed
Metadaten
Titel
Pyogenic arthritis, pyoderma gangrenosum, and acne (PAPA) syndrome: differential diagnosis of septic arthritis by regular detection of exceedingly high synovial cell counts
verfasst von
W. Löffler
P. Lohse
T. Weihmayr
W. Widenmayer
Publikationsdatum
01.03.2017
Verlag
Springer Berlin Heidelberg
Erschienen in
Infection / Ausgabe 4/2017
Print ISSN: 0300-8126
Elektronische ISSN: 1439-0973
DOI
https://doi.org/10.1007/s15010-017-0996-1

Weitere Artikel der Ausgabe 4/2017

Infection 4/2017 Zur Ausgabe

Leitlinien kompakt für die Innere Medizin

Mit medbee Pocketcards sicher entscheiden.

Seit 2022 gehört die medbee GmbH zum Springer Medizin Verlag

„Überwältigende“ Evidenz für Tripeltherapie beim metastasierten Prostata-Ca.

22.05.2024 Prostatakarzinom Nachrichten

Patienten mit metastasiertem hormonsensitivem Prostatakarzinom sollten nicht mehr mit einer alleinigen Androgendeprivationstherapie (ADT) behandelt werden, mahnt ein US-Team nach Sichtung der aktuellen Datenlage. Mit einer Tripeltherapie haben die Betroffenen offenbar die besten Überlebenschancen.

So sicher sind Tattoos: Neue Daten zur Risikobewertung

22.05.2024 Melanom Nachrichten

Das größte medizinische Problem bei Tattoos bleiben allergische Reaktionen. Melanome werden dadurch offensichtlich nicht gefördert, die Farbpigmente könnten aber andere Tumoren begünstigen.

CAR-M-Zellen: Warten auf das große Fressen

22.05.2024 Onkologische Immuntherapie Nachrichten

Auch myeloide Immunzellen lassen sich mit chimären Antigenrezeptoren gegen Tumoren ausstatten. Solche CAR-Fresszell-Therapien werden jetzt für solide Tumoren entwickelt. Künftig soll dieser Prozess nicht mehr ex vivo, sondern per mRNA im Körper der Betroffenen erfolgen.

Frühzeitige HbA1c-Kontrolle macht sich lebenslang bemerkbar

22.05.2024 Typ-2-Diabetes Nachrichten

Menschen mit Typ-2-Diabetes von Anfang an intensiv BZ-senkend zu behandeln, wirkt sich positiv auf Komplikationen und Mortalität aus – und das offenbar lebenslang, wie eine weitere Nachfolgeuntersuchung der UKPD-Studie nahelegt.

Update Innere Medizin

Bestellen Sie unseren Fach-Newsletter und bleiben Sie gut informiert.